Kyverna Therapeutics, Inc. · NASDAQ:KYTX
GordonMD Global Investments LP reported a 7.00% stake in Kyverna Therapeutics, Inc. (Schedule 13G)
Event Nov 13, 2025 · Filed Nov 17, 2025
GordonMD Global Investments LP reported a 7.00% stake in Kyverna Therapeutics, Inc., 3,058,485 shares, as a passive investor on Nov 13, 2025. Filed Nov 17, 2025 (Schedule 13G).
- Stake
- 7.00%
- Shares
- 3,058,485
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GordonMD Global Investments LP | 7.00% | 3,058,485 |
| GordonMD Long Biased Master Fund LP | 6.20% | 2,735,783 |
| GordonMD Long Biased GP LLC | 6.20% | 2,735,783 |
| Craig D. Gordon | 7.00% | 3,058,485 |
| GordonMD Global Investments GP LLC | 7.00% | 3,058,485 |
Source
Related
- Kyverna Therapeutics, Inc.
- GordonMD Global Investments LP
- Kyverna Therapeutics, Inc. shareholders
- Schedule 13G · Orin Hirschman · Oct 19, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Clark Ian T · May 29, 2026
- Form 4 · Cohen Fred E · May 29, 2026